Clinical Trials
4 trialsNCT03296553 2022-01-27
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.
National Institute of Cancerología
Phase 2 Completed
NCT01441063 2020-10-27
Tocilizumab for KSHV-Associated Multicentric Castleman Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00096538 2015-11-25
Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00194467 2008-01-10
Suppression of Oral HHV8 Shedding With Valganciclovir
University of Washington
Phase 2 Completed